Netherlands Diabetes Market, By CGM, SMBG, Insulin Pen & Pump, Companies

1. Netherlands Diabetes Market Netherlands Diabetes Market

2. Report Description and Highlights Netherland has observed a rise in the prevalence of type 2 diabetes during the last decade. As the Dutch population is ageing and the incidence of obesity is a significant risk factor for diabetes is increasing, survival is improving, and multiple screening initiatives are implemented in the Netherlands. In 2013, nearly half the Dutch population suffered from at least one chronic disorder. One of the disorders with a high disease burden and reduction in quality of life is diabetes mellitus. Netherlands Diabetes Market is gardened to reach USD 4.48 Billion by the year 2025. Netherlands Diabetes Market

3. Netherlands Diabetes Market In the Netherlands, the prevalence of diabetes mellitus (DM) is increasing rapidly. Netherlands care for diabetes is mainly concentrated in primary health care, with responsibility for most aspects of care in the hands of general practitioners. In general, primary health care in The Netherlands provides a good standard of care for subjects with DM. Another point of concern is the rise in the prevalence of obesity, leading to a vast increase in subjects with metabolic syndrome. DM (diabetes mellitus) care and its provision will continue to play an important role in health care in The Netherlands. The market of Continuous Glucose Monitoring (CGM) Device, Self Monitoring Blood Glucose Device, Insulin Pen and Insulin Pump are growing due to the rising awareness for diabetes in Netherland. Diabetes care in The Netherlands has reached a high level of quality, but there is still an opportunity for further improvement. Not only is it a medical challenge but at least as much a burden for the Dutch economy and society. To fight with these risk factors, the Netherlands rolled out national health programs. In 2018, The National Prevention Agreement which was approved and it sets out ambitious goals to make the Netherlands healthier by 2040, but it was in March 2019 that they are still far from reach. Netherlands Diabetes Market

4. Netherlands Diabetes Market Over the past decade, the National Action program Diabetes (NAD) was implemented in the Netherlands. It is aimed to introduce the Care Standard (CS) for diabetes using a specific implementation plan and to pilot in several regions. In the year December 2019, Roche received CE Mark for its Accu-Chek SugarView app. Accu-Chek SugarView is the first app that checks the blood glucose ranges by taking pictures with the Smartphone camera without the requirement for a blood glucose meter. Request a free sample copy of the report:https://www.renub.com/request-sample-page.php?gturl=netherlands-diabetes-market-p.php Netherlands Diabetes Market

5. Netherlands Diabetes Market Renub Research report titled “Netherlamds Diabetes Market & Forecast, By Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Self Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Insulin Pen Analysis – (User, Types – Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Insulin Pump Analysis- (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies) Companies (B. Braun Melsungen AG, Eli Lilly and Company, Artsana S.p.A, BD, Novo Nordisk A/S, Owen Mumford Ltd, Ypsomed AG, Medtronic, Insulet Corporation, LifeScan Inc., Abbott Laboratories, Dexcom Inc and Roche)” provides a complete analysis of Netherland Insulin Delivery Devices Market. Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=netherlands-diabetes-market-p.php Netherlands Diabetes Market

6. Netherlands Diabetes Market Segments Market based on Devices 1.    Continuous Glucose Monitoring (CGM)2.    Self Monitoring Blood Glucose (SMBG)3.    Insulin Pen4.    Insulin Pump Netherlands Diabetes Sub-Segment Analysis Continuous Glucose Monitoring (CGM) 1.1.    Glucose Sensor Market & Forecast1.2.    CGM Transmitter Market & Forecast1.3.    CGM User1.4.    CGM Reimbursement Netherlands Diabetes Market

7. Netherlands Diabetes Market Forecast for Netherlands Diabetes Market Share (%) - by Segments (2020 - 2026) Source: Renub Research Analysis Note: These are dummy figures; actual data given in the report Netherlands Diabetes Market

8. Netherlands Diabetes Market 2. SMBG 2.1.    Test Strips Market and Forecast 2.2.    Lancet Market and Forecast2.3.    Meter Market and Forecast 2.4.    Blood Glucose (SMBG) Users2.5.    Blood Glucose Devices Reimbursement   3. Insulin Pen Market 3.1.    Disposable Insulin Pen 3.2.    Reusable Insulin Pen3.3.    Smart Insulin Pen 3.4.    Insulin Pen Needle Market3.5.    Insulin Pen Users 3.6.    Reimbursement Policies 4. Insulin Pump Market 4.1.    Insulin Pump Market 4.2.    Insulin Pump Users4.3.    Insulin Pump Products 4.4.    Reimbursement Policies Netherlands Diabetes Market

9. Netherlands Diabetes Market All the 14 Companies Studied in the Report have been Studied from 3 Points •    Company Overview•    Recent Developments•    Financial Insight Company Analysis 1.    B. Braun Melsungen AG 2.    Eli Lilly and Company3.    Artsana S.p.A 4.    BD5.    Novo Nordisk A/S 6.    Owen Mumford Ltd7.    Ypsomed AG 8.    Medtronic9.    Insulet Corporation 10.    LifeScan Inc.11.    Abbott Laboratories 12.    Roche13.    Dexcom Inc Netherlands Diabetes Market

10. Netherlands Diabetes Market • Browse Related Report : • Sweden Diabetes Market • Germany Diabetes Market • Contact Us • Tel: +1-678-302-0700 (US), • +91-120-421-9822 (INDIA) • Email: info@renub.com Netherlands Diabetes Market